logo

BridgeBio Pharma Inc (BBIO) Stock: 52-Week Performance Insights and Trading Volume

SLGG

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. BridgeBio Pharma Inc’s current trading price is -42.51% away from its 52-week high, while its distance from the 52-week low is 17.85%. The stock’s price range over this period has fluctuated between $21.62 and $44.32. The company, operating within the financial sector, had a trading volume of approximately 1.97 million for the day, which was noticeably higher than the average daily share volume of 1.92 million over the last 3 months.

In terms of market performance, BridgeBio Pharma Inc had a fairly uneven. The highest value for the stock in the past year was $44.32 on 12/28/23, and the lowest value was recorded at $21.62 on 06/24/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

BridgeBio Pharma Inc (BBIO) has experienced a quarterly decline of -0.08% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.21B and boasts a workforce of 550 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 25.94, with a change in price of -2.00. Similarly, BridgeBio Pharma Inc recorded 2,000,852 in trading volume during the last 100 days, posting a change of -7.28%.

BBIO Stock Stochastic Average

Today’s raw stochastic average for BridgeBio Pharma Inc over the last 50 days is 29.32%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 67.74%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 36.64% and 34.08%, respectively.

BBIO Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -36.88%.However, over the last six months, we can see a stronger performance of -8.44%. Over the last 30 days, the price of BBIO has leaped by -0.59%. And in the last five days, it has surged by 6.88%.

Most Popular